Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

The Food and Drug Administration (FDA) on Tuesday announced actions to phase out the use of petroleum based food dyes in U.S.

Wild animals that have acquired adaptations to maximize their reproductive output in some of the world's most extreme ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

Feline diabetes mellitus (DM) is currently understood to have strong similarities to human type 2 diabetes. Veterinarians ...

Our extensive research on the Global United States Human Insulin Market (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, investment ...

Discover how fermented foods, fatty fish, bitter greens, resistant starches and spices can help manage blood sugar and ...